<DOC>
	<DOCNO>NCT00279175</DOCNO>
	<brief_summary>Impaired contractile function heart attack heart major cause `` heart failure '' limiting quality life prognosis , prevent even optimal standard therapy , include immediate balloon/stent dilation infarct vessel . The aim REPAIR-AMI trial investigate whether infusion progenitor cell infarct vessel ( successful reperfusion therapy ) may improve leave ventricular contractile function compare placebo therapy . After bone marrow aspiration progenitor cell enrich via centrifugation method .</brief_summary>
	<brief_title>REPAIR-AMI : Intracoronary Progenitor Cells Acute Myocardial Infarction ( AMI )</brief_title>
	<detailed_description>- The study double-blind , placebo-controlled , randomize , multicenter trial . - Patients acute myocardial infarction , undergo successful reperfusion therapy include . - All patient undergo bone marrow aspiration 3 6 day infarction . - After cell processing , enrich bone marrow-derived progenitor cell placebo medium infuse direct infarct relate artery stop-flow . In addition , leave ventricular angiography perform . - After 4 month leave ventricular angiography repeat . The primary endpoint difference change leave ventricular ejection fraction two group .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients acute myocardial infarction ( ST elevation least 2 lead &gt; = 0.2 mV V1 , V2 V3 &gt; = 0.1 mV lead ) , treat one following procedures Either acute PCI stent implantation within 24 hour symptom onset treatment thrombolysis within 12 hour symptom onset follow PCI stent implantation within 24 hour thrombolysis . Acute PCI / stent implantation successful ( residual stenosis visually &lt; 30 % TIMI flow &gt; = 2 ) . At time inclusion patient longer require i.v . catecholamine mechanical hemodynamic support ( aortic balloon pump ) Significant regional wall motion abnormality LV angiogram time acute PCI ( ejection fraction &lt; = 45 % visual estimation ) . Maximal CK elevation &gt; = 400 U/l ( measure 37° C ) significant MB fraction &gt; 6 % Age 18 80 Years Written inform consent Regional wall motion abnormality outside area involve index acute myocardial infarction . Need revascularize additional vessel , outside infarct artery . Arteriovenous malformation aneurysms Active infection ( CRP &gt; 10 mg/dl ) , fever diarrhea within last 4 week . Chronic inflammatory disease HIV infection active hepatitis Neoplastic disease without documented remission within past 5 year . Cerebrovascular insult within 3 month Impaired renal function ( creatinine &gt; 2 mg/dl ) time cell therapy Significant liver disease ( GOT &gt; 2x upper limit ) spontaneous INR &gt; 1,5 ) Anemia ( hemoglobin &lt; 8.5 mg/dl ) Platelet count &lt; 100.000/µl Hypersplenism Known allergy intolerance clopidogrel , heparin abciximab . History bleed disorder Gastrointestinal bleeding within 3 month Major surgical procedure trauma within 2 month Uncontrolled hypertension Pregnancy Mental retardation Previously perform stem / progenitor cell therapy Participation another clinical trial within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Acute myocardial infarction</keyword>
</DOC>